ERBB2 and non-small cell lung carcinoma: Stable disease (SD) was observed in 12 (of 29) patients in part 1A, of whom 6 had ER+HER2− mBC, 5 had CRPC and 1 had NSCLC (Extended Data Figs. 2d, 3a and 4).